5′-Adenosine monophosphate-activated protein kinase-mammalian target of rapamycin axis as therapeutic target for age-related macular degeneration

Rejuvenation Research

Volumn 14, Issue 6, 2011, Pages 651-660

  Hyttinen, Juha M T ^a   Petrovski, Goran ^b,c   Salminen, Antero ^a,d   Kaarniranta, Kai ^a,d  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c UNIVERSITY OF DEBRECEN   (Hungary)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ADENYLATE KINASE; LIPOFUSCIN; MAMMALIAN TARGET OF RAPAMYCIN; METFORMIN; RAPAMYCIN; RESVERATROL; VASCULOTROPIN INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; STILBENE DERIVATIVE; TARGET OF RAPAMYCIN KINASE;

ARTICLE; AUTOPHAGY; CYTOTOXICITY; DISEASE COURSE; DRUG TARGETING; HUMAN; LYSOSOME; MITOSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN AGGREGATION; RETINA MACULA AGE RELATED DEGENERATION; RETINA PIGMENT DEGENERATION; ANIMAL; BAGG ALBINO MOUSE; BIOLOGICAL MODEL; CHEMISTRY; CONFOCAL MICROSCOPY; INFLAMMATION; METABOLISM; METHODOLOGY; MOUSE; PIGMENT EPITHELIUM; RETINA; REVIEW;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; AUTOPHAGY; HUMANS; INFLAMMATION; LIPOFUSCIN; LYSOSOMES; MICE; MICE, INBRED BALB C; MICROSCOPY, CONFOCAL; MODELS, BIOLOGICAL; OXIDATIVE STRESS; RETINA; RETINAL PIGMENT EPITHELIUM; STILBENES; TOR SERINE-THREONINE KINASES;

EID: 83755186590     PISSN: 15491684     EISSN: 15578577     Source Type: Journal    
DOI: 10.1089/rej.2011.1220     Document Type: Article

References (91)

1. Kaarniranta K, Salminen A, Haapasalo A, Soininen H, Hiltunen M. Age-related macular degeneration (AMD): Alzheimer's disease in the eye? J Alzheimers Dis 2011 24 615-631.
2. Bressler NM. Antiangiogenic approaches to age-related macular degeneration today. Ophthalmology 2009;116:15-23.
3. Ciulla TA, Rosenfeld PJ. Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration. Curr Opin Ophthalmol 2009;20:158-165.
4. Kaarniranta K, Hyttinen JMT, Ryhanen T, Viiri J, Paimela T, Toropainen E, Sorri I, Salminen A. Mechanisms of protein aggregation in the retinal pigment epithelial cells. Front Biosci (Elite Ed) 2010;2:1374-1384.
5. Donoso LA, Kim D, Frost A, Callahan A, Hageman G. The role of inflammation in the pathogenesis of age-related macular degeneration. Surv Opthalmol 2006;91:137-152. (Pubitemid 43269939)
6. Nowak JZ. Age-related macular degeneration (AMD) pathogenesis and therapy. Pharmacol Report 2006;58:353-363. (Pubitemid 44111070)
7. Terman A, Brunk UT. Lipofuscin. Int J Biochem Cell Biol 2004;36:1400-1404. (Pubitemid 38625820)
8. Kirkin V, McEwan DG, Novak I, Dikic I. A role for ubiquitin in selective autophagy. Mol Cell 2009;34:259-269.
9. Mizushima N. Autophagy: Process and function. Genes Dev 2009;21:2861-2873. (Pubitemid 350133435)
10. Eskelinen EL, Saftig P. Autophagy: A lysosomal degradation pathway with a central role in health and disease. Biochim Biphys Acta 2008;1793:664-673.
11. Yang Z, Klionsky DJ. Eaten alive: A history of macroautophagy. Nature Cell Biol 2010;12:814-822.
12. Levine B, Klionsky DJ. Development by self-digestion: Molecular mechanisms and biological functions of autophagy. Dev Cell 2004;6:463-477. (Pubitemid 38456176)
13. McCray BA, Taylor JP. The role of autophagy in age-related neurodegeneration. Neurosignals 2008;16:75-84. (Pubitemid 350308323)
14. Arjamaa O, Nikinmaa M, Salminen A, Kaarniranta K. Regulatory role of HIF-1a in the pathogenesis of age-related macular degeneration (AMD). Ageing Res Rev 2009;8:349-358.
15. Kaarniranta K, Salminen A, Eskelinen EL, Kopitz J. Heat shock proteins as gatekeepers of proteolytic pathways Implications for age-related macular degeneration (AMD). Ageing Res Rev 2009;8:128-139.
16. Salminen A, Kaarniranta K. Regulation of the aging process in autophagy. Trends Mol Med 2009;15:217-224.
17. Ryhanen T, Hyttinen JMT, Kopitz J, Rilla K, Kuusisto E, Mannermaa E, Viiri J, Holmberg CI, Immonen I, Meri S, Parkkinen J, Eskelinen EL, Uusitalo H, Salminen A, Karniranta K. Crosstalk between Hsp70 molecular chaperone, lysosomes and proteasomes in autophagy-mediated proteolysis in human retinal pigment epithelial cells. J Cell Mol Med 2009;13:3616-3631.
18. Viiri J, Hyttinen JMT, Ryhanen T, Rilla K, Paimela T, Kuusisto E, Siitonen A, Urtti A, Salminen A, Kaarniranta K. p62/sequestosome 1 as a regulator of proteasome inhibitorinduced autophagy in human retinal pigment epithelial cells. Mol Vis 2010;16:1399-1414.
19. Wang AL, Lukas TJ, Yuan M, Du N, Tso MO, Neufeld AH. Autophagy and exosomes in the aged retinal pigment epithelium: Possible relevance to drusen formation and agerelated macular degeneration. PLoS One 2009;24:e4160.
20. Kaarniranta K. Autophagy hot topic in AMD. Acta Ophthalmol 2010;88:387-388.
21. Bergamini E, Cavallini G, Donati A, Gori Z. The role of macroautophagy in the ageing process, anti-ageing intervention and age-related diseases. Int J Biochem Cell Biol 2004;36:2392-2404. (Pubitemid 39119754)
22. Canto A, Auwerx J. AMP-activated protein kinase and its downstream transcriptional pathways. Cell Mol Life Sci 2010;67:3407-3423.
23. Hayer-Hansen M, Jaattela M. AMP-activated protein kinase: A universal regulator of autophagy? Autophagy 2007 3 381-283.
24. Petrovski G, Gurusamy N, Das DK. Resveratrol in cardiovascular health and disease. Ann NY Acad Sci 2011;1215:22-33.
25. Hardie DG. AMP-activated/SNF1 protein kinases: Conserved guardians of cellular energy. Nat Rev Mol Cell Biol 2007;8:774-785. (Pubitemid 47462132)
26. Qin S, De Vries GW. a2 but not a1 AMP-activated protein kinase mediates oxidative stress-induced inhibition of retinal pigment epithelium cell phagocytosis of photoreceptor outer segments. J Biol Chem 2008;283:6744-6751.
27. Qin S, Rodrigues GA. Differential roles of AMPKa1 and AMPKa2 in regulating 4-HNE-induced RPE cell death and permeability. Exp Eye Res 2010;91:818-824.
28. Lage R, Dieáguez C, Vidal-Puig A, Loápez M. AMPK: A metabolic gauge regulating whole-body energy homeostasis. Trends Mol Med 2008;14:539-549.
29. Warden SM, Richardson C, O'Donnell J, Stapleton D, Kemp BE, Witters LA. Post-translational modifications of the b-1 subunit of AMP-activated protein kinase affect enzyme activity and cellular localization. Biochem J 2001;354:275-283. (Pubitemid 32209863)
30. Meley D, Bauvy C, Houben-Weerts JH, Dubbelhuis PF, Helmond MT, Codogno P, Meijer AJ. AMP-activated protein kinase and the regulation of autophagic proteolysis. J Biol Chem 2006;281:34870-34879. (Pubitemid 46036526)
31. Liang J, Shao SH, Xu ZX, Hennessy B, Ding Z, Larrea M, Kondo S, Dumont DJ, Gutterman JU, Walker CL, Slingerland JM, Mills GB. The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat Cell Biol 2007;9:218-224. (Pubitemid 46420865)
32. Samari HR, Seglen PO. Inhibition of hepatocytic autophagy by adenosine, aminoimdazole-4-carboxyamide riboside, and N6-mercaptopurine riboside. Evidence for involvement of amp-activated protein kinase. J Biol Chem 1998;273: 23758-23763. (Pubitemid 28435708)
33. Viana R, Aguado C, Esteban I, Moreno D, Viollet B, Knecht E, Sanz P. Role of AMP-activated protein kinase in autophagy and proteasome function. Biochem Biophys Res Commun 2008;369:964-968.
34. Alexander A, Cai S-L, Kim J, Nanez A, Sahin M, MacLean K H, Inoki K, Guan K-L, Shen J, Person MD, Kusewitt D, Mills GB, Kastan MB, Walker CL. ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. Proc Natl Acad Sci USA 2010;107:4153-4158.
35. Ouchi N, Shibata R, Walsh K. AMP.activated protein kinase signaling stimulates VEGF expression and angiogenesis in skeletal muscle. Circ Res 2005;96:838-846. (Pubitemid 40604967)
36. Wang S, Dale GL, Song P, Viollet B, Zou MH. AMPKalpha1 deletion shortens erythrocyte life span in mice: Role of oxidative stress. J Biol Chem 2010;25:19976-19985.
37. Zou M-H, Hou X-Y, Shi C-M, Kirkpatick S, Liu F, Goldman MH, Cohen RA. Activation of 5'-AMP-activated kinase is mediated through c-Src and phosphoinositide 3-kinase activity during hypoxia-reoxygenation of bovine aortic endothelial cells. Role of peroxynitrite. J Biol. Chem 2003;278: 34003-34010. (Pubitemid 37553236)
38. Meares GP, Hughes KJ, Jaimes KF, Salvatori AS, Rhodes CJ, Corbett JA. AMP-activated protein kinase attenuates nitric oxide-induced cell death. J Biol Chem 2010;285:3191-3200.
39. Emerling BM, Weinberg F, Snyder C, Burgess Z, Mutlu GM, Viollet B, Budlinger GR, Chandel NS. Hypoxic activation of AMPK is dependent on mitochondrial ROS but independent of an increase in AMP/ATP ratio. Free Rad Biol Med 2009;46:1386-1391.
40. Brunk UT, Wihlmark U, Wrigstad A, Roberg K, Nilsson SE. Accumulation of lipofuscin within retinal pigment epithelial cells results in enhanced sensitivity to photooxidation. Gerontology 1995;41:201-212. (Pubitemid 26019917)
41. Kopitz J, Holz FG, Kaemmerer E, Schutt F. Lipids and lipid peroxidation products in the pathogenesis of age-related macular degeneration. Biochimie 2004;86:825-831. (Pubitemid 39602762)
42. Bergmann M, Schu tt F, Holz FG, Kopitz J. Inhibition of the ATP-driven proton pump in RPE lysosomes by the major lipofuscin fluorophore A2-E may contribute to the pathogenesis of age-related macular degeneration. FASEB J 2004; 18:562-564.
43. Sparrow JR, Boulton M. RPE lipofuscin and its role in retinal pathobiology. Exp Eye Res 2005;80:595-606. (Pubitemid 40602960)
44. He X, Hahn P, Iacovelli J, Wong R, King C, Bhisitkul R, Massaro-Giordano M, Dunaief JL. Iron homeostasis and toxicity in retinal degeneration. Prog Retin Eye Res 2007;26: 649-673. (Pubitemid 47615564)
45. B1asiak J, Sk1odowska A, Uliná ska M, Szaflik JP. Iron and age-related macular degeneration. Klin Oczna 2009;111:174-177.
46. Kurz T, Terman A, Gustafsson B, Brunk UT. Lysosomes and oxidative stress in aging and apoptosis. Biochim Biophys Acta 2008;1780:1291-1303.
47. Petrovski G, Das DK. Does autophagy take a front seat in lifespan extension? J Cell Mol Med 2010 14 2543-2551.
48. Bai X, Jiang Y. Key factors in mTOR regulation. Cell Mol Life Sci 2010;67:239-253.
49. Lane WS, Galat A, Harding MW, Schreiber SL. Complete amino acid sequence of the FK506 and rapamycin binding protein, FKBP, isolated from calf thymus. J Protein Chem 1991;10:151-160.
50. Easton JB, Houghton PJ. mTOR and cancer therapy. Oncogene 2006;25:6436-6446. (Pubitemid 44582287)
51. Lee C-H, Inoki K, Guan K-L. mTor pathway as a target in tissue hypertrophy. Annu Rev Pharmacol Toxicol 2007;47:443-467.
52. Inoki K, Li Y, Xu T, Guan KL. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev 2003;17:1829-1834. (Pubitemid 36944560)
53. Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, A, Vasquez DS, Turk BE, Shaw RJ. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 2008;30: 214-226. (Pubitemid 351626684)
54. Jung CH, Ro S-H, Cao J, Otto NM, Kim D-H. mTOR regulation of autophagy. FEBS Lett 2010;584:1287-1295.
55. Brugarolas J, Lei K, Hurley RL, Manning BD, Reiling JH, Hafen E, Witters LA, Ellisen LW, Kaelin WGl. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev 2004;18: 2893-2904. (Pubitemid 39602308)
56. Liu L, Das S, Losert W, Parent CA. mTORC2 regulates neutrophil chemotaxis in a cAMP-and RhoA-dependent fashion. Dev Cell 2010;19:845-857.
57. Sofer A, Lei K, Johannessen CM, Ellisen LW. Regulation of mTOR and cell growth in response to energy stress by REDD1. Mol Cell Biol 2005;25:5834-5845. (Pubitemid 40946541)
58. Salminen A, Kauppinen A, Hyttinen JMT, Toropainen E, Kaarniranta K. Endoplastic reticulum stress in age-related macular degeneration: Trigger for neovascularization. Mol Med 2010;16:535-542.
59. Stefaánsson E, Geirsdoá ttir A, Sigurdsson H. Metabolic physiology in age related macular degeneration. Prog Retin Eye Res 2011;30:72-80.
60. Chen Y, Wang J, Cai J, Sternberg P. Altered mTOR signaling in senescent retinal pigment epithelium. Invest Ophthalmol Vis Sci 2010;51:5314-5319.
61. Zhao C, Yasumura D, Li X, Matthes M, Lloyd M, Nielsen G, Ahern K, Snyder M, Bok D, Dunaief JL, LaVail MM, Vollrath D. mTOR-mediated dedifferentiation of the retinal pigment epithelium initiates photoreceptor degeneration in mice. J Clin Invest 2011;121: 369-383.
62. Li Y, Huang D, Xia X, Wang Z, Luo L, Wen R. CCR3 and choroidal neovascularization. PLoS One 2011;6:e17106.
63. Guba M, von Breitenbuch P, Steinbauer M, Koehl G, Fiegel S, Hornung M, Bruns CJ, Zuelke C, Farkas S, Anthuber M, Jauch KW, Geissler EK. Rapamycin inhibits primary and metastatic tumor growth by angiogenesis: Involvement of vascular endothelial growth factor. Nat Med 2002;8:128-135. (Pubitemid 34155123)
64. Kokkinopoulos I, Shahabi G, Colman A, Jeffery G. Mature peripheral RPE cells have an intrinsic capacity to proliferate; a potential regulatory mechanism for age-related cell loss. PloS ONE 2011;6:e18921.
65. Kamada Y, Funakoshi T, Shintani T, Nagano K, Ohsumi M, Ohsumi Y. Tor-mediated induction of autophagy via an Apg1 protein kinase complex. J Cell Biol 2000;150:1507-1513.
66. Jung CH, Jun CB, Ro S-H, Kim YM, Otto NM, Cao J, Kundu M, Kim DH. ULK-Atg13-FIP complexes mediate mTOR signaling to the autophagy machinery. Mol Biol Cell 2009;20:1992-2003.
67. Hosokawa N, Hara T, Kaizuka T, Kishi C, Takamura A, Miura Y, Iemura S, Natsume T, Takehana K, Yamada N, Guan JL, Oshiro N, Mizushima N. Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex mediates mTOR signaling and is essential for autophagy. Mol Biol Cell 2009;284:1981-1991.
68. Chan EY, Longatti A, McKnight NC, Tooze SA. Kinaseinactivated ULK proteins inhibit autophagy via their conserved C-terminal domains using an Atg-13-independent mechanism. Mol Cell Biol 2009;29:157-171.
69. Ganley IG, Lam du H, Wang J, Ding X, Chen S, Jiang X. ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy. J Biol Chem 2009;284:12297-12305.
70. Hanada T, Noda NN, Satomi Y, Ichimura Y, Fujioka Y, Takao T, Inagaki F, Ohsumi Y. The Atg12-Atg5 conjugate has a novel E3-like activity for protein lipidation in autophagy. J Biol Chem 2007;282:37298-37303.
71. Sou YS, Waguri S, Iwata J, Ueno T, Fujimura T, Hara T, Sawada N, Yamada A, Mizushima N, Uchiyama Y, Kominami E, Tanaka K, Komatsu M. The Atg8 conjugation system is indispensable for the proper development of autophagic isolation membranes in mice. Mol Biol Cell 2007;19:4762-4775.
72. Kim J, Kundu M, Viollet B, Guan KL. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nature Cell Biol 2011;13:132-141.
73. Lee JW, Park S, Takahashi Y, Wang H-G. The association of AMPK with ULK 1 regulates autophagy, PLoS One 2010 5 e15394.
74. Denzer K, Kleijmeer MJ, Heijnen HF, Stoorvogel W, Geuze HJ. Exosome: From internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci 2000;113: 3365-3374.
75. Schorey JS, Bhatnagar S. Exosome function: From tumor immunology to pathogen biology. Traffic 2008;9:871-881. (Pubitemid 351639493)
76. Sullivan JE, Brocklehurst KJ, Marley AE, Carey F, Carling D, Beri RK. Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell-permeable activator of AMP-activated protein kinase. FEBS Lett 1994;353: 33-36. (Pubitemid 24312538)
77. Leclerc GM, Leclerc GJ, Fu G, Barredo JC. 2010. AMPKinduced activation of Akt by AICAR is mediated by IGF-1R dependent and independent mechanisms in acute lymphoblastic leukemia. J Mol Signal 2010;5:15.
78. Buzzai M, Jones RG, Amaravadi RK, Lum JJ, DeBerardinis RJ, Zhao F, Viollet B, Thompson CB. Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth. Cancer Res 2007;67:6745-6752. (Pubitemid 47105521)
79. Hardie DG. Sensing of energy and nutrients by AMPactivated protein kinase. Am J Clin Nutr 2011;93(Suppl): 891S-816S.
80. Puljak L, Parameswara V, Dolovcak S, Waldrop SL, Emmett D, Esser V, Fitz JG, Kilic G. Evidence for AMPK-dependent regulation of exocytosis of lipoproteins in a model liver cell line. Exp Cell Res 2008;314:2100-2109.
81. Dejneka NS, Kuroki AM, Fosnot J, Tang W, Tolentino MJ, Bennett J. Systemic rapamycin inhibits retinal and choroidal neovascularizaion in mice. Mol Vision 2004;10:964-972. (Pubitemid 41358195)
82. Stahl A, Paschek L, Martin G, Gross NJ, Feltgen N, Hansen LL, Agostini HT. Rapamycin reduces VEGF expression in retinal pigment epithelium (RPE) and inhibits RPE-induced sprouting angiogenesis in vitro. FEBS Lett 2008:582:3097-3102.
83. Kunchithapautham K, Coughlin B, Lemasters JJ, Rohrer B. Differential effects of rapamycin on rods and cones during light-induced stress in albino mice. Invest Ophthalmol Vis Sci 2011;52:2967-2975.
84. Kubota S, Kurihara T, Ebinuma M, Kubota M, Yuki K, Sasaki M, Noda K, Ozawa Y, Oike Y, Ishida S, Tsubota K. Resveratrol prevents light-induced retinal degeneration via suppressing activator protein-1 activation. Am J Pathol 2010;177:1725-1731.
85. Khan AA, Dace DS, Ryazanov AG, Kelly J, Apte RS. Resveratrol regulates pathological angiogenesis by a eukaryotic elongation factor-2-kinase-reguated pathway. Am J Pathol 2010;177:481-492.
86. Mukherjee S, Dudley JI, Das DK. Dose-dependency of resveratrol in providing health benefits. Dose Response 2010,8:478-500.
87. Sheu SJ, Liu NC, Chen JL. Resveratrol protects human retinal pigment epithelial cells from acrolein-induced damage. J Ocul Pharmacol Ther 2010;26:231-236.
88. King RE, Kent KD, Bomser JA. Resveratrol reduces oxidation and proliferation of human retinal pigment epithelial cells via extracellular signal-regulated kinase inhibition. Chem Biol Interact 2005;151:143-149. (Pubitemid 40208564)
89. Dasgupta B, Milbrandt J. Resveratrol stimulates AMP kinase activity in neurons. Proc Natl Adac Sci USA 2007;104:7217-7222. (Pubitemid 47186035)
90. Vingtdeux V, Giliberto L, Zhao H, Chandakkar P, Wu Q, Simon JE, Janle EM, Lobo J, Ferruzi MG, Davies P, Marambaud P. AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism. J Biol Chem 2010;285:9100-9113.
91. Hwang JT, Kwon DY, Park OJ, Kim MS. Resveratrol protects ROS-induced cell death by activating AMPK in H9c2 cardiac muscle cells. Genes Nutr 2008;2:323-326. (Pubitemid 351447706)